Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Natera, Inc. Director's Dealing 2021

Oct 6, 2021

30253_dirs_2021-10-05_27c85699-b187-409f-9bbb-882c81e1ed12.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Natera, Inc. (NTRA)
CIK: 0001604821
Period of Report: 2021-10-02

Reporting Person: Chapman Steven Leonard (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-10-02 Common Stock M 3125 Acquired 41196 Direct
2021-10-04 Common Stock S 1831 $108.2042 Disposed 39365 Direct
2021-10-04 Common Stock S 500 $109.26 Disposed 38865 Direct
2021-10-04 Common Stock S 154 $111.54 Disposed 38711 Direct
2021-10-04 Common Stock M 2084 $13.01 Acquired 40795 Direct
2021-10-04 Common Stock M 2084 $20.27 Acquired 42879 Direct
2021-10-04 Common Stock S 1784 $107.8869 Disposed 41095 Direct
2021-10-04 Common Stock S 1870 $108.8050 Disposed 39225 Direct
2021-10-04 Common Stock S 256 $110.2430 Disposed 38969 Direct
2021-10-04 Common Stock S 258 $111.54 Disposed 38711 Direct
2021-10-04 Common Stock S 1084 $105.8759 Disposed 11812 Indirect
2021-10-04 Common Stock S 5139 $106.9660 Disposed 6673 Indirect
2021-10-04 Common Stock S 4966 $108.0664 Disposed 1707 Indirect
2021-10-04 Common Stock S 1239 $108.8064 Disposed 468 Indirect
2021-10-04 Common Stock S 431 $110.2314 Disposed 37 Indirect
2021-10-04 Common Stock S 37 $111.54 Disposed 0 Indirect
2021-10-05 Common Stock S 1608 $110.91 Disposed 37103 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-10-02 Restricted Stock Unit $ M 3125 Disposed Common Stock (3125) Direct
2021-10-04 Stock Option (right to buy) $13.01 M 2084 Disposed 2029-01-10 Common Stock (2084) Direct
2021-10-04 Stock Option (right to buy) $20.27 M 2084 Disposed 2029-04-11 Common Stock (2084) Direct

Footnotes

F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F2: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 24, 2021.

F3: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.59 to $108.57 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.05 to $109.60 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2021, as amended on May 14, 2021

F6: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.48 to $108.42 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.49 to $109.23 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F8: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.15 to $110.65 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F9: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Rosewood Trust on August 13, 2021.

F10: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.39 to $106.2450 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F11: The Rosewood Trust is an irrevocable spendthrift trust for the benefit of the Reporting Person and other discretionary beneficiaries, pursuant to Nevada Revised Statutes Chapter 166. Under the Rosewood Trust, the Reporting Person has no enforceable rights to distributions. The Rosewood Trust is a fully discretionary trust and the distribution decisions for the Rosewood Trust are vested in a committee. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.

F12: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.4550 to $107.43 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F13: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.5550 to $108.52 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F14: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.5950 to $109.14 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F15: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.6250 to $110.47 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F16: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs in compliance with Rule 10b5-1.

F17: The RSUs vest over four years. 25% of the RSUs vested on January 2, 2020 and the remaining shares vest in 12 equal quarterly installments thereafter.

F18: The option shares vest over four years. 25% of the option shares vested and became exercisable on January 2, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.

F19: The option shares vest over four years. 25% of the option shares vested and became exercisable on March 22, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.